Építés alatt – nem éles oldal
Belépés

What researchers published on Fabry-betegség

2563 papers, newest first.

Showing 40 of 2563

  • Esetismertetés[A novel GLA variant in classic Fabry disease: a case report].Zhonghua nei ke za zhi
  • Generation of an induced pluripotent stem cell line from a Fabry disease patient carrying the GLA c.640-801G>A mutation.Stem cell research
  • Megfigyeléses vizsgálatAnti-Drug Antibodies in Patients with Fabry Disease Treated with Agalsidase-Alpha or -Beta: A Retrospective Italian Multicenter Study.Cells
  • AAV-mediated genome targeting of the GLA cDNA in newborn and juvenile Gla KO mice achieves long-term correction of Fabry disease.Molecular therapy. Advances
  • Improving molecular diagnosis of fabry disease: functional validation of novel splicing variants in GLA.Orphanet journal of rare diseases
  • ÁttekintésImplementing evolving Fabry disease management recommendations in resource-constrained settings: lessons from South Africa.Orphanet journal of rare diseases
  • Leadless Pacemaker Implantation in Fabry Disease With Permanent Atrial Fibrillation and Bradycardia: Diagnostic and Implantation Guidance by Preprocedural Cardiac Magnetic Resonance Imaging.Clinical case reports
  • Raised Amylase as a Potential Marker of Vascular Dysfunction and Inflammation in Fabry Disease.JIMD reports
  • Early Change in Left Ventricular Global Longitudinal Strain and Long-Term Cardiovascular Outcomes in Fabry Disease: A Prognostic Tool for Enzyme Replacement Therapy.JACC. Cardiovascular imaging
  • Migalastat Versus Enzyme Replacement Therapy in Treatment-Naïve Fabry Disease: Real-World Evidence From the followME Fabry Pathfinders Registry.Journal of inherited metabolic disease
  • Relative versus absolute globotriaosylsphingosine changes and kidney outcomes in Fabry disease.Molecular genetics and metabolism reports
  • EsetismertetésVentricular tachycardia ablation in late-onset phenotype Fabry disease: a case report.European heart journal. Case reports
  • Impact of Anti-drug Antibodies in Patients with Fabry Disease under Enzyme Replacement Therapy: Long-Term Outcomes.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • Megfigyeléses vizsgálatDisease severity and lyso-Gb3 are associated with early echocardiographic markers of cardiac involvement in Fabry disease: a single-center observational study.Orphanet journal of rare diseases
  • Peripheral and cardiac determinants of exercise intolerance in classic Anderson-Fabry disease: insights from cardiopulmonary exercise testing and advanced echocardiography.Orphanet journal of rare diseases
  • Biochemical Endocrine and Skeletal Findings in Adults with Fabry Disease: A Descriptive Single-Center Study.Biomolecules
  • Early mitophagy defects and impaired mitochondrial energy metabolism drive target organ damage progression: Lessons from the Fabry heart.Cell reports
  • EsetismertetésFabry's Disease, Valvular Disease and Infective Endocarditis: A Rare Intersection.JACC. Case reports
  • "On-Site Family Screening" in Fabry Disease: An Innovative Model for Identifying At-Risk Relatives.Journal of clinical medicine
  • Heterogeneous biochemical responses to migalastat in real-world cases of Fabry disease.European journal of medical genetics
  • Impact of the protein corona in RGD-functionalized nanoliposomes delivering enzymatic replacement therapy for Fabry disease.International journal of pharmaceutics
  • EsetismertetésSilent Cardiac Progression in a Woman With Fabry Disease Despite Normal Baseline CMR.JACC. Case reports
  • ÁttekintésThe role of dermatological manifestations in the early diagnosis of Fabry disease: a scoping review.Frontiers in medicine
  • ÁttekintésThyroid involvement in lysosomal storage diseases: current evidence and clinical perspectives.Reviews in endocrine & metabolic disorders
  • Screening of fabry disease in patients with left ventricular hypertrophy: a single-center study in Mexico.Orphanet journal of rare diseases
  • Esetismertetés[Fabry disease misdiagnosed as obstructive hypertrophic cardiomyopathy: a case report].Zhonghua xin xue guan bing za zhi
  • NF-κB p65 iso5 Δ6/7 and p65 iso5 Δ10 isoforms drive immune-inflammatory remodeling in Fabry disease and GLA variants of uncertain significance.Frontiers in immunology
  • [Fabry disease and hypertrophic obstructive cardiomyopathy: from phenotypic mimicry to precision diagnosis and treatment].Zhonghua xin xue guan bing za zhi
  • Prevalence of migalastat-amenable variants in patients with Fabry disease from Brazil, Argentina, and Colombia: an observational study.Frontiers in genetics
  • Myosin inhibitor therapy in Fabry cardiomyopathy with dynamic left ventricular outflow obstruction.American heart journal plus : cardiology research and practice
  • Clinical and Laboratory Characteristics of Fabry Disease in Children and Adults: A Focus on Early Kidney Findings.Journal of clinical medicine
  • Molecular and Structural Characterization of Five Novel GLA Gene Variants in Fabry Disease.International journal of molecular sciences
  • NGAL as a Biomarker of Tubular Injury and Glomerular Dysfunction in Fabry Nephropathy.Cells
  • ÁttekintésNovel GLA Variants: 10 Experts' Tips for the Clinical Assessment of Fabry Disease.Journal of clinical medicine
  • Safety, Efficacy, and Pharmacokinetics of Agalsidase Alfa in Treatment-Naive Chinese Patients with Fabry Disease: 52-Week Phase 3, Open-Label, Single-Arm Study.Advances in therapy
  • EsetismertetésCase Report: Fabry cardiomyopathy associated with a novel truncating GLA variant, c.837_838delinsAT, p.(Gln280Ter).Frontiers in medicine
  • Megfigyeléses vizsgálatLongitudinal assessment of the retinal phenotype in patients with Fabry disease undergoing continuous enzyme replacement and/or chaperone therapy.Orphanet journal of rare diseases
  • EsetismertetésPediatric Fabry disease revealed by early neuropathic symptoms: a case report.Oxford medical case reports
  • Multicentric screening for Fabry disease in patients with kidney replacement therapy in the Italian Region of Veneto.Minerva urology and nephrology
  • Genome sequencing reveals the prevalence of Fabry disease-causing variants in Japan: Evidence from the Tohoku Medical Megabank.Genetics in medicine open